Moreover, ARFIP2 silencing blocks HCC cell proliferation, invasion, and migration, whereas its overexpression induces epithelial-to-mesenchymal transition (EMT) and inhibits apoptosis and autophagy via the Akt signaling pathway [19]. Here, ARFIP2 is linked to hepatocellular carcinoma.